Clinical Trials

Accrual Status
Limit to SWOG Trials

1040 Results

View
Closed
Phase
SWOG Clinical Trial Number
SWOG-7940

Evaluation of 5-FU vs. A Phase II Drug in Metastatic Adeno- carcinoma of the Large Bowel
Activated
02-27-1980
Closed
05-05-1982
Closed
Phase
SWOG Clinical Trial Number
SWOG-8062

Evaluation of Vindesine in Head and Neck Cancer
Activated
02-25-1980
Closed
10-23-1981
Closed
Phase
SWOG Clinical Trial Number
SWOG-8061

Evaluation of Vindesine in Gastrointestinal Cancer
Activated
02-22-1980
Closed
09-28-1982
Closed
Phase
SWOG Clinical Trial Number
SWOG-7902

Combined Modality Therapy with Chemotherapy, Radio- therapy and Surgery vs. Radiotherapy & Surgery in AdvancedPreviously Untreated (Unrestable) Stage III & IV Epidermoid Cancer of the Head and Neck
Activated
02-18-1980
Closed
06-02-1982
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-7956

Study of Postinfarction Nephrectomy and Medroxy- progesterone Acetate (Depo-Provera) in Metastatic Renal Cell Carcinoma
Activated
02-09-1980
Closed
01-19-1984
Closed
Phase
SWOG Clinical Trial Number
SWOG-7980

Study of Cis-Diammine Dichlorophlatinum-II (DDP) for Recurrent Gliomas
Activated
02-05-1980
Closed
05-11-1982
Closed
Phase
SWOG Clinical Trial Number
SWOG-7982

Chlorozotocin in the Treatment of Advanced Sarcomas
Activated
02-04-1980
Closed
05-11-1982
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8102

Whole Brain Irradiation and Intrathecal Methotrexate in the Treatment of Solid Tumor Leptomeningeal Metastases
Activated
02-04-1980
Closed
03-22-1985
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-7983

Radiation Therapy in Combination with CCNU in Patients with Incompletely Resected Gliomas of the Brain, Grade I and II
Activated
02-04-1980
Closed
03-22-1985
Closed
Phase
SWOG Clinical Trial Number
SWOG-7959

Evaluation of MGBG in Metastatic Renal Carcinoma
Activated
12-14-1979
Closed
12-03-1980
Closed
Phase
SWOG Clinical Trial Number
SWOG-7958

Evaluation of m-AMSA in Metastatic or Recurrent Epithelial Carcinomas of the Female Genital Tract
Activated
12-14-1979
Closed
01-31-1983
Closed
Phase
SWOG Clinical Trial Number
SWOG-7930

Vindesine in Adults with Metastatic Malignant Melanoma
Activated
12-07-1979
Closed
05-10-1982
Closed
Phase
SWOG Clinical Trial Number
SWOG-7937

Evaluation of m-AMSA in Metastatic Carcinoma of the GU Tract Except Renal Carcinoma
Activated
11-20-1979
Closed
09-10-1982
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-7936

Evaluation of Mitomycin-C + Vincristine + Bleomycin + Cis-Platinum vs. Mitomycin-C + Cis-Platinum in the Treatment of Disseminated Carcinoma of the Uterine Cervix
Activated
11-19-1979
Closed
11-14-1983
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-7924

Multimodal Therapy for Limited Small Cell Carcinoma of the Lung
Activated
11-02-1979
Closed
10-29-1982
Closed
Phase
SWOG Clinical Trial Number
SWOG-7969

Hepatic Infusion and Systemic Combination Chemotherapy in the Treatment of Unresectable Hepatoma
Activated
10-18-1979
Closed
03-30-1983
Closed
Phase
SWOG Clinical Trial Number
SWOG-7970

Evaluation of m-AMSA in Acute Leukemia
Activated
10-11-1979
Closed
05-11-1982
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-7931

Evaluation of n-AMSA in Metastatic or Advanced Adenocarcinoma of the Stomach and Pancreas
Activated
10-05-1979
Closed
04-14-1981
Closed
Phase
SWOG Clinical Trial Number
SWOG-7934

Evaluation of Acridinylamino-Methansesulfon-M-Aninsidide in Mestastatic Squamous Carcinoma of the Head and Neck
Activated
10-05-1979
Closed
04-14-1981
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-7927/28

Chemotherapy for Multiple Myeloma
Activated
09-25-1979
Closed
12-01-1982